NCT06811779

Comparison of Effectiveness of Disinfectants

Comparison of Effectiveness of Sodium Hypochlorite and Chlorhexidine Gluconate for Disinfection of Gutta Percha Cones

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 124 (actual)
• Sponsor: Armed Forces Institute of Dentistry, Pakistan · Academic / Other
• Sex: All
• Age: 20 Years – 40 Years
• Healthy volunteers: Accepted

Summary

This is a comparative experimental study to compare the efficacy of chemical disinfection agents , sodium hypochlorite and chlorhexidine gluconate in decontaminating gutta percha cones

Detailed description

The study design is a comparative study which was done to compare the efficacy of chemical disinfection agents on decontaminating the gutta percha cones . In this study, 124 standardized size-80 gutta-percha (GP) cones (Dentsply, Germany) were used to assess the efficacy of chemical disinfectants. The cones were first sterilized using ethylene oxide to ensure baseline sterility. Following sterilization, 124 cones were allocated into two experimental groups (n = 62 each) for contamination. group A . gp were immersed in 20ml of Enterococcus faecalis solution group B . gp were immersed in 20 ml of human saliva in patients undergoing root canal therapy samples were incubated at 37°C for 72 hours to ensure uniform and thorough contamination after incubation period cones were dried and divide into subgroups based on disinfectant agent applied . The cones were immersed in disinfectant agent for 1 min and 10 min . Cones were dried again and immersed in brain heard infusion broth samples were again incubated at 37°C for 72 hours The presence of bacterial growth was determined by assessing turbidity in the broth, indicating viable microorganisms.

Conditions

• Root Canal Infection

Interventions

Type	Name	Description
DRUG	Sodium Hypochlorite	Sodium hypochlorite used in 5% concentration for disinfection
DRUG	Chlorhexidine	Chlorhexidine 0.2% concentration for disinfection

Timeline

• Start date: 2024-03-24
• Primary completion: 2024-06-24
• Completion: 2024-06-25
• First posted: 2025-02-06
• Last updated: 2025-02-06

Locations

1 site across 1 country: Pakistan

Regulatory

• FDA-regulated drug study